ESR 12

Development of advanced online dosimetry algorithms for photodynamic therapy of tumours
Host institution/company
SpectraCure AB (Sweden)
Dr. Nina Reistad, Division of Atomic Physics, Department of Physics, Lund University

Dr. Johannes Swartling, Spectracure AB
Type of contract
36-months full-time research grant within the PHAST-ETN project
Brief description of the project
SpectraCure is a world-leader in research and development of dosimetry algorithms for photodynamic therapy (PDT) of internal cancer tumours. The work is conducted in collaboration with academic groups and hospitals in Europe and North America.
The objective of the ESR project is to further develop the dosimetry algorithms that are now used in clinical trials, by retrospective analysis of the treatment outcome and improvement of the models and numerical methods in the algorithms.
The activity will include analysis of medical data, optimization, model development and software implementation, tissue optical measurements, and field work in clinics.

Planned secondments at Lund University (Sweden), Politecnico di Milano (Italy), and Tyndall Institute (Ireland).
Applicants should hold or expect to attain, as a minimum an MSc in Electronics, Optical Engineering or Photonics, Physics, Computer Science, or related area
Knowledge and Experience
A demonstrated knowledge of at least two of the following: photonics, spectroscopy, lasers, data analysis, computational methods or computer science.

Research project carried out in at least one of the above disciplines
Skills and Competencies
- Applicants whose first language is not English must submit evidence of competency in English.
- Evidence of interest, aptitude and research experience in the above disciplines.
Further information
For any informal queries, please contact Dr. Johannes Swartling by email at
Information sheet Apply now

Related technology

Other ESR Positions

Integrated liquid biopsy for cancer diagnostics via genomic markers detection
Point-of-care Raman microspectroscopy for detecting tumour markers in body liquids
Hybrid diffuse optical monitoring and theranostics with blood flow and oxygen metabolism biomarkers on pre-clinical models
Time-gated diffuse optical spectroscopy for deep tissue diagnostics
ESR 13
Diffuse optical monitoring and prediction of neoadjuvant chemotherapy for personalized breast cancer management
ESR 14
Tissue identification for surgical guidance using biophotonics
ESR 15
Micro-camera for hyperspectral imaging for in-vivo probing

Stay in touch

subscribe to our newsletter service